Functional Bladder Problems
|
|
- Isabella Janice Matthews
- 6 years ago
- Views:
Transcription
1 european urology supplements 6 (2007) available at journal homepage: Functional Bladder Problems Emmanuel Chartier-Kastler * Department of Urology, Hospital Pitié-Salpêtrière, University Paris VI, Boulevard de L Hôpital 83, Paris, France Article info Keywords: Bladder outlet obstruction (BOO) Interstitial cystitis (IC) Painful bladder syndrome (PBS) Tamsulosin Ultrasound Uroflowmetry Abstract Objectives: This paper summarises relevant new information on functional bladder problems presented during the New Horizons in Urology closed meeting, with special focus on bladder outlet obstruction (BOO) and painful bladder syndrome/interstitial cystitis (PBS/IC). Methods: Experts in the field of functional bladder problems selected and discussed the most relevant new findings during a closed meeting in Marbella, Spain. Furthermore, the delegates opinions on representative clinical case studies were assessed by interactive voting. Voting results were commented on by an expert panel. Results: Uroflowmetry and ultrasound hold promise as noninvasive tools to diagnose BOO. a 1 -Adrenoceptor antagonists can reduce bladder wall hypertrophy in patients with BOO. A very interesting finding for clinical practice is the evaluation of the tenderness on bladder palpation as initial screening for IC patients. Furthermore, botulinum toxin A and cyclosporine A seems promising in the treatment of patients with PBS/IC, but more data are needed to confirm these findings. Conclusion: New data on diagnosis and treatment of patients with BOO and PBS/IC, which seem promising for daily clinical practice, were discussed during the closed meeting. # 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved. * Tel. +33 (1) ; Fax: +33 (1) address: emmanuel.chartier-kastler@psl.aphp.fr. 1. Introduction Functional bladder problems are common among men and women of all ages, and include overactive bladder, incontinence, bladder outlet obstruction (BOO), urinary tract infections, and painful bladder syndrome/interstitial cystitis (PBS/IC) [1]. This review paper will focus on diagnosis and management of patients with BOO and PBS/IC. The International Continence Society (ICS) defines BOO as the generic term for obstruction during voiding, characterised by increased detrusor pressure and reduced urine flow rate. It is usually diagnosed by studying the synchronous values of flow rate and detrusor pressure [2]. Benign prostatic obstruction is a form of bladder outlet obstruction caused by benign prostatic enlargement due to histologic benign prostatic hyperplasia (BPH) [2]. The most common causes of BOO in men are age-related bladder dysfunctions superimposed with pathologies such as BPH, urethral stricture, bladder stones, and bladder or pelvic tumours [3]. From the basic and animal literature, we have some information regarding the progressive response of the bladder to obstruction. Levin et al. [4] described the different steps of what happens regarding the bladder after /$ see front matter # 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved. doi: /j.eursup
2 european urology supplements 6 (2007) obstruction. During the initial stage, men with BOO demonstrate a rapid enlargement of the bladder wall attributable to smooth muscle hypertrophy, urothelial and fibroblast hyperplasia, collagen deposition in the detrusor, and connective tissue reorganisation. Then, the bladder enters the compensated stage, which is characterised by a stable bladder mass and the bladder s function remains greater than 80% of normal. At some point thereafter, the bladder enters the decompensated stage because of ischemia; this period is characterised by a progressive increase in bladder mass and a progressive decrease of the bladder function and compliance. In general, if the obstruction is released during the compensated stage, there is a rapid and full restoration of normal, or nearly normal, bladder function. If the obstruction is released during the decompensated stage, there is only a partial recovery proportional to the level of decompensation. Until today, individual progression and time for decompensation were not predictable. The resulting obstruction often produces lower urinary tract symptoms (LUTS). The most common symptoms of BOO are classified as voiding symptoms including weak urinary flow, hesitancy, intermittency, terminal dribbling, incomplete bladder emptying, retention, and abdominal pain, and storage symptoms including nocturia, frequency, urgency, and urinary incontinence [2]. PBS/IC is a syndrome characterised by chronic irritative voiding symptoms, and suprapubic and/or pelvic pain without any known aetiologic factor [5]. This syndrome has clinically been considered a disorder affecting primarily women. However, the prevalence of PBS/IC symptoms varies considerably on the basis of its definition and is now known to be greater in men than was previously believed [6].Itis still not clear what should be the base definition of PBS. The ICS defined PBS as the complaint of suprapubic pain related to bladder filling, accompanied by other symptoms such as increased daytime and nighttime frequency, in the absence of proven urinary infection or other obvious pathology [2]. 2. Bladder outlet obstruction 2.1. Diagnosis of patients with BOO Assessment of medical history and physical examination are critical in the primary evaluation of patients with LUTS and BOO. Basic evaluation of these patients includes concomitant analysis of uroflowmetry and postvoid residual (PVR) analysis. In case of treatment failure or a doubtful diagnosis, further evaluation is indicated, which includes more invasive techniques, such as urodynamics with pressure-flow evaluation, cystoscopy, and ultrasound. An urodynamic evaluation is considered the gold standard to demonstrate the presence of BOO [3]. The invasive nature of urodynamics is often regarded as a disadvantage. Several noninvasive alternatives to determine BOO have been proposed. Already in 1996, the results of a study supported the use of the International Prostate Symptom Score (IPSS) to identify patients with BOO. There appeared to be a significant correlation between the IPSS score and the presence of BOO. When the total IPSS was >28 or the voiding subscore >15, the probability of BOO was >0.91 [7]. In an abstract presented during the American Urological Association conference, the potential of noninvasive uroflowmetry to predict the presence of BOO was evaluated [8]. In total, data from 3416 men who underwent uroflowmetry and pressure-flow studies during the last 12 yr were analysed. Of these men, 1535 were obstructed and had a BOO index >40. Multiple linear regression revealed that maximum urinary flow rate (Q max ), postvoid residual urine (PVR), and bladder-voiding efficiency, defined as voided volume/(voided volume + PVR), were significant variables to predict BOO (all p < 0.001) with a sensitivity of 69% and a specificity of 71%. On the basis of these variables, a table was developed that allows physicians to estimate the probability of BOO following uroflowmetry. This method can be particularly useful in units with limited access to urodynamics. Another promising, but not a new, tool to identify the presence of BOO is measurement of detrusor wall thickness (DWT) by means of ultrasound. Oelke et al. [9] performed DWT measurements at three different locations of the anterior bladder wall in 160 patients when their bladder was fully filled. A DWT cut-off value 2 mm can be used to classify the majority of patients with BOO. This accuracy seems to be high enough for a noninvasive classification of obstructed men in daily clinical practice. However, a lot of bias regarding this tool and its measurement technique can be reported Management of patients with BOO With regard to the management of patients with BOO, some recent studies specifically evaluated the effect of a 1 -adrenoceptor (AR) antagonists on DWT. Lluel et al. [10] observed that treatment with alfuzosin (3 mg/kg/d for 7 d) significantly reduced the increased bladder weight in obstructed rats ( p < 0.05). These results were in line with a multi-
3 712 european urology supplements 6 (2007) Fig. 1 The a 1 -adrenoceptor antagonist tamsulosin significantly reduced bladder wall hypertrophy in obstructed patients. Bladder wall hypertrophy was evaluated by ultrasound-estimated bladder weight (UEBW) [11]. NS = not significant. centre study evaluating the effect of tamsulosin on DWT of obstructed patients. After a 4-wk run-in period with no drug treatment, 9 nonobstructed patients and 18 obstructed patients received 0.4 mg once daily tamsulosin for a period of 6 mo [11]. The primary objective of the study was to evaluate the effect on bladder wall hypertrophy by using ultrasound-estimated bladder weight (UEBW). Treatment with tamsulosin significantly reduced UEBW in obstructed patients ( p < 0.05) (Fig. 1). These data suggest that a 1 -AR antagonists may have a direct effect on the obstructed bladder Clinical case study related to BOO The case of a 72-year-old man with storage and voiding symptoms and two episodes of haematospermia during the last year was discussed. The patient had been treated with dopamine therapy for Parkinson s disease during 4 yr and with angiotensin-converting enzyme inhibitors for high blood pressure. Several possible causes of voiding difficulties at nighttime (ie, reduced concentration or increased sympathetic tone) were pointed out during the panel discussion. The experts also referred to a recently published paper suggesting a possible physiologic cause of nocturia in some patients [12] Diagnostic evaluation Digital rectal examination of the patient revealed the presence of BPH with a prostate of about 40 g without other abnormalities. Neurologic examination of the patient revealed extrapyramidal syndrome related to Parkinson s with a tremor, but without evidence of other pathologies affecting the reflexes or perineal sensibility. In addition, the Fig. 2 Results from interactive voting on a representative case indicate that an urodynamic study is the preferred tool for diagnostic evaluation. Surprisingly, watchful waiting and cystoscopy are still frequently chosen. Only a minority of the participants chose urethrocystography as a diagnostic tool. patient had a PSA value of 5.2 ng/ml, no signs of prostate cancer, a Q max of 8 ml/s, a voided volume of 233 ml, and a PVR of 120 ml. Interactive voting revealed that about 14% of the delegates would advise watchful waiting, whereas 14% would perform a cystoscopy (Fig. 2). The majority of the delegates agreed with the proposition of the subject expert to perform a urodynamic study to further evaluate the patient. Urodynamic analysis showed that the patient had a high detrusor pressure during micturition, suggesting obstruction. During the panel discussion, it was stated that patients should first complete a voiding chart before a urodynamic study because the former gives information on the global diuresis of the patient, as well as of his nocturnal diuresis, which is essential to evaluate the patients nocturia. Therefore, the voiding chart should be the basis for further urodynamic analysis Treatment About half of the participants selected a transurethral resection of the prostate (TURP) as treatment option (Fig. 3). Surprisingly, only 9% would have performed a temporary prostatic stent. Nevertheless, the patient received a Fabian s stent (Urethrospiral 1, Porges, France), which is a temporary prostatic stent. The expert explained that this treatment was chosen to assess the outcome of the patient after surgery. Patients with neurologic diseases such as Parkinson s disease and extrapyramidal syndrome can develop sphincter deficiency after surgery. He advised to follow-up the clinical symptoms of the patient for a period of 3 mo, followed by another uroflowmetry and PVR analysis.
4 european urology supplements 6 (2007) is not only a PBS but is also associated with the presence of bladder pain, urgency, and submucosal haemorrhages, which means that not all patients with PBS have IC [5]. Recently, the presence of bladder tenderness on bladder palpation during vaginal examination seemed to be useful as initial screening tool for IC patients [16]. The sensitivity of tenderness on bladder palpation for the diagnosis of IC was 90.4%; specificity was 89.1%. This screening might be helpful to determine which patients need further evaluation or not. Fig. 3 Results from interactive voting indicate that about half of the participants chose a transurethral resection of the prostate (TURP) as treatment option for a patient with bladder outlet obstruction, whereas a prostatic stent was a less favoured option. In case of a positive result, a TURP could be performed at the same time of removal of the prostatic stent. There was some discussion on the use of a combination of anticholinergics and a 1 -AR antagonists, and depending on his nighttime voiding, antidiuretics to treat his Parkinson s disease and voiding difficulties. Most of the attendees agreed on a step-by-step management of these types of patients from diagnosis to treatment adapted to each patient. 3. Painful bladder syndrome/interstitial cystitis 3.1. Diagnosis of patients with PBS/IC PBS/IC is underestimated, underdiagnosed, and frequently inadequately treated in clinical practice. Most patients with PBS/IC will see at least five different physicians over a period of 5 yr before the correct diagnosis is made [13,14]. Nevertheless, it is important to know how to diagnose patients with PBS/IC because time delays in accurate diagnosis can worsen the patient s condition. However, since symptoms of PBS/IC are similar to those of other bladder disorders and because there is no definitive test to identify PBS/IC, diagnosis of PBS/IC is made by exclusion of other treatable conditions. Although there is some overlap between symptoms in patients with overactive bladder (OAB) and PBS, it is clear that patients with bladder pain must be classified as PBS [15]. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) developed diagnostic criteria to standardise the diagnosis of IC on the basis of patient s symptoms and cystoscopic findings [5].IC 3.2. Management of patients with PBS/IC Because of the elusive aetiology of PBS/IC, many forms of treatment have been attempted. Treatments for IC include behavioural therapies (eg, dietary modification and pelvic floor exercise), oral therapies (eg, pentosan polysulfate sodium [PPS], amitriptyline, and hydroxyzine), and intravesical therapies (eg, dimethylsulfoxide and heparin) (Table 1) [14]. The clinical efficacy of PPS for the treatment of IC has been demonstrated in several studies. In two randomised placebo-controlled studies, significant improvement in symptoms was reported after 3 mo of treatment with PPS [17]. Promising new medical treatments include botulinum toxin A (BTX-A) [18] and cyclosporine A [19] (Table 1). Giannantoni et al. [18] demonstrated that BTX-A intravesical injections are effective in the short-term management of PBS. In this study, 14 patients (12 women and 2 men) were prospectively included. Under short general anaesthesia, patients were given injections of 200 U of BTX-A diluted in 20 ml 0.9% NaCl. A voiding chart and the Visual Analog Scale (VAS) for pain quantification were completed before, and 1 and 3 mo after treatment. Table 1 Treatment of interstitial cystitis (IC) [14] Behavioural therapy Dietary modification Pelvic floor exercise Physical/emotional relief Oral therapy Pentosan polysulfate sodium (PPS) Tricyclic antidepressants (eg, amitriptyline, doxepin, imipramine) Antihistamines (eg, H 1 - and H 2 -receptor antagonists, hydroxyzine, cimetidine) Nonsteroidal anti-inflammatory drugs Bladder analgesics Intravesical therapy Dimethylsulfoxide (DMSO) Heparin Silver nitrate Other Botulinum toxin A (BTX-A) Cyclosporine A
5 714 european urology supplements 6 (2007) Fig. 4 Botulinum toxin A (BTX-A) injections significantly decreased daytime and nighttime urinary frequency as well as the Visual Analog Scale (VAS) score for bladder pain at 1- and 3-mo follow-up [18]. Before treatment, mean daytime and nighttime urinary frequencies were 14.2 and 4.5, respectively. The mean VAS score for bladder pain was 9.3 at baseline, but was significantly reduced at 1- and 3-mo follow-up ( p < 0.01) (Fig. 4). At the same time points, daytime and nighttime urinary frequency was significantly decreased ( p < 0.01 and p < 0.05, respectively). Sairanen et al. [19] compared cyclosporine A to PPS for the treatment of patients with IC in a randomised, open-label, prospective multicentre study. At 6 mo, treatment with 1.5 mg/kg cyclosporine A twice daily significantly reduced 24-h micturition frequency compared with 100 mg PPS three times daily ( p < 0.001) (Fig. 5). The clinical response rate was 75% for cyclosporine A compared with 19% for PPS ( p < 0.001). However, caution is warranted when using cyclosporine A for patients with IC because this drug is an immunosuppressive drug usually used for organ transplant patients. Because of potential toxicities, patients on cyclosporine A have to be carefully followed up. Surgery is another treatment alternative, but it is reserved for only patients who are refractory to conventional Fig. 5 Cyclosporine A significantly decreased 24-h micturition frequency compared with pentosan polysulfate sodium (PPS) in patients with interstitial cystitis (IC) [19]. Fig. 6 Results from interactive voting indicate that approximately an equal amount of participants chose between a urodynamic study and cystoscopy under general anaesthesia, and bladder biopsies as the tool for diagnostic evaluation of a patient with painful bladder syndrome/interstitial cystitis (PBS/IC). One of five delegates opted for the voiding diary. treatment. Nevertheless, optimal management of PBS/IC is limited by the fact that standardised guidelines have not been developed to ensure a consistent and effective approach for treatment. Neuromodulation is becoming increasingly important for the treatment of patients with PBS/IC who are refractory to conservative treatment. Sacral nerve stimulation, for example, has been successfully applied in PBS/IC patients in a number of studies [20] Clinical case study related to PBS/IC Another case discussed at the closed expert meeting was that of a 42-year-old woman with three children. The patient underwent a left oophorectomy at the age of 39 and was complaining of severe daytime and nighttime frequency, and a painful bladder. Furthermore, she had suprapubic pain, which was relieved by voiding Diagnostic evaluation Because of progressive aggravation of symptoms over 5 yr, the patient underwent several examinations and treatments (several cystoscopies, colonoscopy and laparoscopy, with multiple therapies), but they did not improve her symptoms. Clinical examination did not reveal any other abnormal features. The patient s intravenous pyelogram and urinalysis were normal. Interactive voting showed that about 40% of the delegates would evaluate this patient by means of urodynamics, whereas 35% would perform a cystoscopy under general anaesthesia and bladder biopsies. Only 19% would use a voiding diary (Fig. 6). The subject expert used a
6 european urology supplements 6 (2007) Fig. 7 Results from interactive voting on a representative case indicate that medical treatment, bladder hydrodistension, and bladder instillations are the preferred treatment options, whereas pelvic floor rehabilitation and surgery are less chosen therapies. voiding diary and performed uroflowmetry, urodynamics, and an outpatient visit cystoscopy. The latter was performed to obtain sufficient information before performing a cystoscopy under general anaesthesia. The outcomes of the urodynamic study revealed that the patient had no OAB, but a painful bladder with severe pain at about 150 ml of bladder filling, which was in line with her voiding diary. However, some delegates remarked that cystoscopy on an outpatient basis is a very painful procedure, which increases the risk that the patient will visit another physician Treatment About 38% of the delegates would have treated the patient with medical therapy such as cimetidine, benzodiazepines, and PPS, whereas 28% would have performed a bladder hydrodistension, and 24% would have performed a bladder instillation as initial treatment plan (Fig. 7). Some of the delegates would have started with a bladder hydrodistension and performed a bladder instillation afterwards. Nevertheless, most participants agreed that all available conservative treatments had to be tried first before initiating more invasive treatment. 4. Conclusions The outcomes of the closed expert meeting clearly demonstrate that there are large variations among urologists in the diagnosis and management of patients with functional bladder problems. This finding reveals the need for continued medical education of practising urologists. Ultrasound and uroflowmetry are noninvasive methods to determine BOO and can be used as initial screening of obstructed patients. New data have been presented, which show a direct effect of a 1 -AR antagonists on the obstructed bladder. In case of PBS/IC, there is clearly need for a standardised definition. The presence of bladder tenderness upon palpation can be useful in clinical practice for the initial screening of patients with IC. BTX-A and cyclosporine A seem promising in the treatment of patients with PBS/IC, but more data are needed to confirm this initial data and to reveal their long-term efficacy and safety. Although progress is being made in the diagnosis and treatment of patients with BOO and PBS/IC, more insight into the aetiology of different bladder problems as well as the development of standardised criteria for diagnosis of bladder problems is needed. Conflicts of interests The author is a consultant for Allergan and Coloplast, a lecturer for Astellas and Medtronic, and investigator of scientific trials for Allergan and Schwarz pharma. The author received financial compensation in all cases. References [1] Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006;50: [2] Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21: [3] Dmochowski RR. Bladder outlet obstruction: etiology and evaluation. Rev Urol 2005;7(Suppl 6):S3 13. [4] Levin RM, Haugaard N, O Connor L, et al. Obstructive response of human bladder to BPH vs. rabbit bladder response to partial outlet obstruction: a direct comparison. Neurourol Urodyn 2000;19: [5] Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28 29, J Urol 1988;140: [6] Clemens JQ, Link CL, Eggers PW, et al. The effect of varying definitions on the prevalence of interstitial cystitis (IC)/ painful bladder syndrome (PBS) in a racially and ethnically diverse sample. J Urol 2006;175:94 (abstract no. 283). [7] Rodrigues NN, D ancona LCA, De Lima LM. Correlation between the prostatic symptom score and a pressure-flow study in the evaluation of symptomatic benign prostatic hyperplasia. J Urol 1996;155: [8] Al-Hayek S, Belal M, Abrams P. How reliable is non-invasive uroflowmetry in predicting the presence of bladder outlet obstruction in men? J Urol 2006;175:437 (abstract no. 1356).
7 716 european urology supplements 6 (2007) [9] Oelke M, Höfner K, de la Rosette JJ, et al. What is the most precise cut-off value of detrusor wall thickness measurement to classify bladder outlet obstruction? Neurourol Urodyn 2006;25 (abstract no. 28). [10] Lluel P, Méen M, Palea S. Alfuzosin reverses bladder hypertrophy induced by bladder outlet obstruction in rats. Eur Urol Suppl 2006;5:121 (abstract no. 396). [11] Tubaro A, Sironi D, Pizzoccaro M, et al. Effect of tamsulosin on bladder wall hypertrophy in patients with lower urinary tract symptoms suggestive of bladder outlet obstruction. Eur Urol Suppl 2003;2(1):158 (abstract no. 624). [12] Natsume O. A clinical investigation of nocturnal polyuria in patients with nocturia: a diurnal variation in arginine vasopressin secretion and its relevance to mean blood pressure. J Urol 2006;176: [13] Curhan GC, Speizer FE, Hunter DJ, et al. Epidemiology of interstitial cystitis: a population based study. J Urol 1999;161: [14] Metts JF. Interstitial cystitis: urgency and frequency syndrome. Am Fam Physician 2001;64: [15] Abrams P, Hanno P, Wein A. Overactive bladder and painful bladder syndrome: there need not be confusion. Neurourol Urodyn 2005;24: [16] Botros S, Miller J, Goldberg R, et al. A simple test to aid in the diagnosis of interstitial cystitis. Neurourol Urodyn 2006;25 (abstract no. 403). [17] In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence. 3rd ed. Health Publication Ltd; p [18] Giannantoni A, Costantini E, Di Stasi SM, et al. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study. Eur Urol 2006;49: [19] Sairanen J, Tammela TL, Leppilahti M, et al. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol 2005;174: [20] Bernstein AJ, Peters KM. Expanding indications for neuromodulation. Urol Clin North Am 2005;32:59 63.
Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center
Diagnostic approach to LUTS in men Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Classification of LUTS Storage symptoms Voiding symptoms Post micturition
More informationLower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist
Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms Storage Symptoms Frequency, urgency, incontinence, Nocturia Voiding Symptoms Hesitancy, poor flow, intermittency,
More informationMANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH
MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH INTRODUCTION (1) Part of male sexual reproductive organ Size
More informationLower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital
Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital 01/02/2018 Lower Urinary Tract Symptoms LUTS - one of
More informationUrogynecology in EDS. Joan L. Blomquist, MD Greater Baltimore Medical Center August 2018
Urogynecology in EDS Joan L. Blomquist, MD Greater Baltimore Medical Center August 2018 One in three like me Voiding Issues Frequency/Urgency Urinary Incontinence neurogenic bladder Neurologic supply
More informationManagement of LUTS after TURP and MIT
Management of LUTS after TURP and MIT Hong Sup Kim Konkuk University TURP & MIT TURP : Gold standard MIT TUIP TUNA TUMT HIFU LASER Nd:YAG, ILC, HoLRP, KTP LUTS after TURP and MIT Improved : about 70% Persistent
More informationIn evaluating a patient with lower urinary tract symptoms (LUTS), urologists
CLINICAL MANAGEMENT OF INTERSTITIAL CYSTITIS Interstitial Cystitis and Lower Urinary Tract Symptoms in Males and Females The Combined Role of Potassium and Epithelial Dysfunction C. Lowell Parsons, MD
More informationAlpha antagonists from initial concept to routine clinical practice
european urology 50 (2006) 635 642 available at www.sciencedirect.com journal homepage: www.europeanurology.com Editorial 50th Anniversary Alpha antagonists from initial concept to routine clinical practice
More informationOveractive Bladder: Diagnosis and Approaches to Treatment
Overactive Bladder: Diagnosis and Approaches to Treatment A Hidden Condition* Many Many patients self-manage by voiding frequently, reducing fluid intake, and wearing pads Nearly Nearly two-thirds thirds
More informationDiagnosis and Mangement of Nocturia in Adults
Diagnosis and Mangement of Nocturia in Adults Christopher Chapple Professor of Urology Sheffield Teaching Hospitals University of Sheffield Sheffield Hallam University UK 23 rd October 2015 Terminology
More informationLUTS after TURP: How come and how to manage? Matthias Oelke
LUTS after TURP: How come and how to manage? Matthias Oelke Department of Urology Global Congress on LUTD, Rome, 26 th June 2015 Disclosures Consultant, speaker, trial participant and/or research grants
More informationIndex. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, of prostate, holmium laser, 485 495 African prune tree (Pygeum africanum), 454 455 Alfuzosin, 445 446 Alpha-adrenergic agonists,
More informationBladder pain syndrome / Interstitial cystitis
Bladder pain syndrome / Interstitial cystitis Terminology The term bladder pain syndrome/interstitial cystitis (BPS/IC) is defined as the presence of chronic pain, pressure, or pelvic discomfort lasting
More informationCHAPTER 6. M.D. Eckhardt, G.E.P.M. van Venrooij, T.A. Boon. hoofdstuk :49 Pagina 89
hoofdstuk 06 19-12-2001 09:49 Pagina 89 Urethral Resistance Factor (URA) Versus Schäfer s Obstruction Grade and Abrams-Griffiths (AG) Number in the Diagnosis of Obstructive Benign Prostatic Hyperplasia
More informationTHE ACONTRACTILE BLADDER - FACT OR FICTION?
THE ACONTRACTILE BLADDER - FACT OR FICTION? Jacob Golomb Department of Urology Chaim Sheba Medical Center Tel Hashomer NEUROGENIC UNDERACTIVE DETRUSOR Central (complete/incomplete): Spinal cord injury-
More informationWhat should we consider before surgery? BPH with bladder dysfunction. Inje University Sanggye Paik Hospital Sung Luck Hee
What should we consider before surgery? BPH with bladder dysfunction Inje University Sanggye Paik Hospital Sung Luck Hee Diagnostic tests in three categories Recommendation: there is evidence to support
More informationVoiding Dysfunction Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU.
Voiding Dysfunction 2009 Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU. Objectives Understand and explain physiologic function and dysfunction of lower urinary tract.
More informationURODYNAMICS IN MALE LUTS: NECESSARY OR WASTE OF TIME?
URODYNAMICS IN MALE LUTS: NECESSARY OR WASTE OF TIME? Andrea Tubaro, MD, FEBU Chairman Department of Urology Sant Andrea Hospital Sapienza University of Rome, Italy Disclosures Consultant, paid speaker,
More informationGUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (BPO)
GUIDELINES ON NON-NEUROGENIC MLE LUTS INCLUDING BENIGN PROSTTIC OBSTRUCTION (BPO) (Text update pril 2014) S. Gravas (chair),. Bachmann,. Descazeaud, M. Drake, C. Gratzke, S. Madersbacher, C. Mamoulakis,
More informationGUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION
GUIDELINES ON NON-NEUROGENIC MLE LUTS INCLUDING BENIGN PROSTTIC OBSTRUCTION (Text update March 2015) S. Gravas (Chair), T. Bach,. Bachmann, M. Drake, M. Gacci, C. Gratzke, S. Madersbacher, C. Mamoulakis,
More informationOveractive Bladder Syndrome
Overactive Bladder Syndrome behavioural modifications to pharmacological and surgical treatments Dr Jos Jayarajan Urologist Austin Health, Eastern Health Warringal Private, Northpark Private, Epworth Overactive
More informationAll about the Prostate
MEN S HEALTH Dr Nick Pendleton January 16 th 2018 All about the Prostate 1 What does it do? Functions of the Prostate 1. Secretes Prostatic Fluid slightly alkaline fluid, 30% of volume of seminal fluid,
More informationAssociation of BPH with OAB: The Plumbing or the Pump?
Association of BPH with OAB: The Plumbing or the Pump? Ryan P. Terlecki, MD FACS Associate Professor of Urology Director, Men s Health Clinic Director, GURS Fellowship in Reconstructive Urology, Prosthetic
More informationThe Evidence for Antimuscarinic Agents in Female Mixed Urinary Incontinence
european urology supplements 5 (2006) 849 853 available at www.sciencedirect.com journal homepage: www.europeanurology.com The Evidence for Antimuscarinic Agents in Female Mixed Urinary Incontinence Stefano
More informationAddendum 1: International Consultation
Reprinted with Permission of the International Consultation on Urological Diseases and the International Continence Society Hanno PM, Cervigni M, Dinis P, Lin A, Nickel JC, Nordling J, van Ophoven A, Ueda
More informationClinical Study Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder
Advances in Urology Volume 2009, Article ID 328364, 4 pages doi:10.1155/2009/328364 Clinical Study Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive
More informationBenign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary
Benign Prostatic Hyperplasia Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied,
More informationNeurogenic bladder. Neurogenic bladder is a type of dysfunction of the bladder due to neurological disorder.
Definition: Neurogenic bladder Neurogenic bladder is a type of dysfunction of the bladder due to neurological disorder. Types: Nervous system diseases: Congenital: like myelodysplasia like meningocele.
More informationGUIDELINES ON NEUROGENIC LOWER URINARY TRACT DYSFUNCTION
GUIDELINES ON NEUROGENIC LOWER URINARY TRACT DYSFUNCTION M. Stöhrer (chairman), D. Castro-Diaz, E. Chartier-Kastler, G. Kramer, A. Mattiasson, J-J. Wyndaele Introduction NLUTD (neurogenic lower urinary
More informationBotulinum Toxin: Applications in Urology
Botulinum Toxin: Applications in Urology Dr. Lee Jonat, PGY-4 Department of Urologic Sciences University of British Columbia Outline Mechanism of Action Technical Considerations Adverse Events Neurogenic
More informationLower Urinary Tract Symptoms BPH vs OAB FLOW vs VOLUME. Matt T. Rosenberg, MD Family Practice Mid Michigan Health Centers Jackson, Michigan
Lower Urinary Tract Symptoms BPH vs OAB FLOW vs VOLUME Matt T. Rosenberg, MD Family Practice Mid Michigan Health Centers Jackson, Michigan 1 Definition of OAB Syndrome or symptom complex defined as urgency,
More informationVOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS
VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS DR. FRANCIS LEE Voiding dysfunction Storage Emptying Common voiding dysfunction in elderly male Emptying BPH Storage Incontinence Overactive bladder Post-prostatectomy
More informationThe Enlarged Prostate Symptoms, Diagnosis and Treatment
The Enlarged Prostate Symptoms, Diagnosis and Treatment MAC00031-01 Rev G Financial support for this seminar has been provided by NeoTract, Inc., the manufacturer of the UroLift System. 1 Today s Agenda
More informationApril Clinical Focus Topic URINARY FREQUENCY
April Clinical Focus Topic URINARY FREQUENCY This month I am focusing on a topic that may seem a little boring. But I would like to look at it from a less common perspective.urinary Frequency and its relationship
More informationDefinitions of IC: U.S. perspective. Edward Stanford MD MS FACOG FACS Western Colorado
Definitions of IC: U.S. perspective Edward Stanford MD MS FACOG FACS Western Colorado PURPOSE OF A DEFINITION? Identifies with specificity those patients who are most likely to have the disease. Identifies
More informationEvaluation and Treatment of Lower Urinary Tract Symptoms in Older Men
Evaluation and Treatment of Lower Urinary Tract Symptoms in Older Men P. Abrams,*, C. Chapple, S. Khoury, C. Roehrborn and J. de la Rosette on behalf of the International Scientific Committee and members
More informationThe Management of Female Urinary Incontinence. Part 1: Aetiology and Investigations
The Management of Female Urinary Incontinence Part 1: Aetiology and Investigations Dr Oseka Onuma Gynaecologist and Pelvic Reconstructive Surgeon 4 Robe Terrace Medindie SA 5081 Urinary incontinence has
More informationPolicy for Prostatism/Lower Urinary Tract Symptoms in men
NHS Halton Clinical Commissioning Group NHS Liverpool Clinical Commissioning Group NHS St Helens Clinical Commissioning Group NHS South Sefton Clinical Commissioning Group NHS Southport and Formby Clinical
More informationEffect of Transurethral Resection of the Prostate Based on the Degree of Obstruction Seen in Urodynamic Study
www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.12.840 Voiding Dysfunction/Female Urology Effect of Transurethral Resection of the Prostate Based on the Degree of Obstruction Seen in Urodynamic
More informationLUTS A plea for a holistic approach. HUBERT GALLAGHER, MCh; FRCSI, FRCSI(Urol) Head of Urology Beacon Hospital
LUTS A plea for a holistic approach. HUBERT GALLAGHER, MCh; FRCSI, FRCSI(Urol) Head of Urology Beacon Hospital LUTS- Classification Men LUTS can be divided into: Storage Voiding Frequency Nocturia Urgency
More informationRecommandations de prise en charge des vessies neurogènes EAU 2006
Annexe 4-1 Recommandations de prise en charge des vessies neurogènes EAU 2006 (Version courte) 685 686 GUIDELINES ON NEUROGENIC LOWER URINARY TRACT DYSFUNCTION M. Stöhrer (chairman), D. Castro-Diaz, E.
More informationHakmin Lee, Minsoo Choo, Myong Kim, Sung Yong Cho, Seung Bae Lee, Hyeon Jeong, Hwancheoul Son
www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.1.47 Original Article - Voiding Dysfunction http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1.47&domain=pdf&date_stamp=2014-1-17 Changes
More informationMultiple Sclerosis. Véronique Phé, MD, PhD Pitié-Salpêtrière Academic Hospital Department of Urology Paris 6 University Paris, FRANCE
Queen Square Uro-neurology course, London, UK 20 th -21 st October 2016 Multiple Sclerosis Véronique Phé, MD, PhD Pitié-Salpêtrière Academic Hospital Department of Urology Paris 6 University Paris, FRANCE
More information김준철 가톨릭대학교의과대학비뇨기과학교실
비뇨기계자율신경병증의치료 김준철 가톨릭대학교의과대학비뇨기과학교실 Introduction Urologic complications have increasingly become a concern in those affected by DM Genitourinary problems are included among these complications, related
More informationMr. GIT KAH ANN. Pakar Klinikal Urologi Hospital Kuala Lumpur.
Mr. GIT KAH ANN Pakar Klinikal Urologi Hospital Kuala Lumpur drgitka@yahoo.com 25 Jan 2007 HIGHLIGHTS Introduction ICS Definition Making a Diagnosis Voiding Chart Investigation Urodynamics Ancillary Investigations
More informationBenign Prostatic Hyperplasia (BPH):
Benign Prostatic Hyperplasia (BPH): Evidence Based Guidelines for Primary Care Providers Jeanne Martin, DNP, ANP-BC Objectives 1. Understand the pathophysiology and prevalence of BPH 2. Select the appropriate
More informationGuidelines on Neurogenic Lower Urinary Tract Dysfunction
Guidelines on Neurogenic Lower Urinary Tract Dysfunction (Text update March 2009) M. Stöhrer (chairman), B. Blok, D. Castro-Diaz, E. Chartier- Kastler, P. Denys, G. Kramer, J. Pannek, G. del Popolo, P.
More informationINVESTIGATION OF LOWER URINARY TRACT SYMPTOMS IN UROLOGICAL OUTPATIENTS USING ORIGINAL IPSS PLUS POST MICTURITION DRIBBLE QUESTIONNAIRE
INVESTIGATION OF LOWER URINARY TRACT SYMPTOMS IN UROLOGICAL OUTPATIENTS USING ORIGINAL IPSS PLUS POST MICTURITION DRIBBLE QUESTIONNAIRE Tadashi Hanail*, Seiji Matsumotol*, Nobutaka Shimizu, Hirotsugu Uemural
More informationManagement of male LUTS in general practice
17 Management of male LUTS in general practice MARK J. SPEAKMAN AND FAITH MCMEEKIN The initial management of lower urinary tract symptoms in men is usually carried out in primary care. The authors explain
More informationLower urinary tract symptoms (LUTS) are common, affecting approximately
Diagn Interv Radiol 2012; 18:277 281 Turkish Society of Radiology 2012 ABDOMINAL IMAGING ORIGINAL ARTICLE Diagnostic values of detrusor wall thickness, postvoid residual urine, and prostate volume to evaluate
More informationAs man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder LUTS 2. Prevalence of BPH LUTS 5
BPH / LUTS Dr Jonny Coxon MA MD MRCS MRCGP DRCOG Beaconsfield Medical Practice, Brighton As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder
More informationVarious Types. Ralph Boling, DO, FACOG
Various Types Ralph Boling, DO, FACOG The goal of this lecture is to increase assessment and treatment abilities for physicians managing urinary incontinence (UI) patients. 1. Effectively communicate with
More informationRELATIONSHIPS BETWEEN AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX, PROSTATE VOLUME, PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
American Urological Association symptom index for BPH RELATIONSHIPS BETWEEN AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX, PROSTATE VOLUME, AND DISEASE-SPECIFIC QUALITY OF LIFE QUESTION IN PATIENTS WITH
More informationTuesday 24 June Poster Session 1: Voiding Dysfunction Chairmen: C. Chapple and L. Stewart
Tuesday 24 June 10.30 11.30 Poster Session 1: Voiding Dysfunction Chairmen: C. Chapple and L. Stewart P001 Can oral antibiotic prophylaxis reduce the rate of infection after conventional urodynamic studies?
More informationOverview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014
Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia Iain McAuley September 15, 2014 Overview Review of the most recent guidelines for ED and BPH ED Guidelines CUA 2006 AUA 2011
More informationMale LUTS. Dr. Brian Ho. Division of Urology Department of Surgery Queen Mary Hospital
Male LUTS Dr. Brian Ho Division of Urology Department of Surgery Queen Mary Hospital Mr. Siu M/78 Known to have HT & DM since 2008 on follow up with General ut-patient Clinic (GPC) Noticed to have worsening
More informationAdverse Events of Intravesical Botulinum Toxin A Injections for Idiopathic Detrusor Overactivity: Risk Factors and Influence on Treatment Outcome
EUROPEAN UROLOGY 58 (2010) 919 926 available at www.sciencedirect.com journal homepage: www.europeanurology.com Incontinence Adverse Events of Intravesical Botulinum Toxin A Injections for Idiopathic Detrusor
More informationEAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION
EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (Text update March 2017) S. Gravas (Chair), T. Bach, M. Drake, M. Gacci, C. Gratzke, T.R.W. Herrmann, S. Madersbacher,
More informationAUCKLAND REGIONAL UROLOGY GUIDELINES AND REFERRAL RECOMMENDATIONS
AUCKLAND REGIONAL UROLOGY GUIDELINES AND REFERRAL RECOMMENDATIONS This document outlines the urological conditions currently funded at Auckland District Health Board (ADHB), Counties Manukau District Health
More informationThe patient, your co-pilot in assessing LUTS
The patient, your co-pilot in assessing LUTS Frank Van der Aa Leuven, Belgium This symposium is supported by Astellas Pharma Europe Ltd., including speaker honoraria and production of materials the slides
More informationInterstitial Cystitis
Interstitial Cystitis Interstitial cystitis (IC) is a chronic bladder condition. Its symptoms are urinary urgency (the feeling that you need to urinate), frequent urination and/or pain anywhere between
More informationManagement of LUTS. Simon Woodhams February 2012
Management of LUTS Simon Woodhams February 2012 The management of lower urinary tract symptoms (LUTS) in men Implementing NICE guidance May 2010 NICE clinical guideline 97 Background Lower urinary tract
More informationSummary. Neuro-urodynamics. The bladder cycle. and voiding. 14/12/2015. Neural control of the LUT Initial assessment Urodynamics
Neuro-urodynamics Summary Neural control of the LUT Initial assessment Urodynamics Marcus Drake, Bristol Urological Institute SAFETY FIRST; renal failure, dysreflexia, latex allergy SYMPTOMS SECOND; storage,
More informationURINARY INCONTINENCE. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara
URINARY INCONTINENCE Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara Definition The involuntary loss of urine May denote a symptom, a sign or a condition Symptom the
More informationLUTS in the modern era. Dr Jon Rees Tyntesfield Medical Group
LUTS in the modern era Dr Jon Rees Tyntesfield Medical Group In the past! Man with urinary symptoms = PROSTATISM Prostatism = TURP TURP unsuccessful = REDO TURP Redo TURP unsuccessful = can t help you!
More informationTable 1. International Consultation on Incontinence recommendations for frail older adults
Table 1. International Consultation on Incontinence recommendations for frail older adults Clinicians need to assess and manage co-existing co morbid conditions which are known to have an impact on continence
More informationBPH / LUTS. Prevalence. Prevalence of BPH. It is abnormal NOT to have benign growth of the prostate with increasing age. Prevalence.
BPH / LUTS Dr Jonny Coxon MA MD MRCS MRCGP DRCOG FECSM Beaconsfield Medical Practice, Brighton & Brighton & Sussex Universities NHS Trust As man draws near the common goal Can anything be sadder Than he
More information2/9/2008. Men Women. Prevalence of OAB. Men: 16.0% Women: 16.9% Prevalence (%) < Age (years)
Definition Botox for Overactive Bladder Donna Y. Deng Assistant Professor UCSF Department of Urology Urinary urgency With or without urge incontinence Usually with frequency & nocturia International Continence
More informationEAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION
EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (Limited text update March 2016) S. Gravas (Chair), T. Bach, A. Bachmann, M. Drake, M. Gacci, C. Gratzke, S. Madersbacher,
More informationProstate Disease. Chad Baxter, MD
Prostate Disease Chad Baxter, MD Managing BPH and LUTS Chad Baxter, MD Department of Urology cbaxter@mednet.ucla.edu 33 nd Annual UCLA Intensive Course in Geriatric Medicine & Board Review Prevalence of
More informationKathleen C. Kobashi, MD, FACS Head, Section of Urology and Renal Transplantation Virginia Mason Medical Center, Seattle, WA
Kathleen C. Kobashi, MD, FACS Head, Section of Urology and Renal Transplantation Virginia Mason Medical Center, Seattle, WA Disclosures Advisory Board and/or Speaker Allergan Medtronic Astellas AUA Guidelines
More informationCase studies: LUTS. Case 1 history. Case 1 - questions. Case 1 - outcome. Case 2 - history. Case 1 learning point 14/07/2015 DR JON REES
Case 1 history Case studies: LUTS DR JON REES A 49 year old male comes to see you he has had gradual deterioration of his flow over the last few years- he saw a colleague of yours 6 weeks ago who recorded
More informationIncontinence: The silent scourge of the young and old. The International Continence Society has. In this article:
Focus on CME at the University of Toronto Incontinence: The silent scourge of the young and old By Sender Herschorn, BSc, MDCM, FRCSC In this article: 1. What is the workup for urinary incontinence? 2.
More informationA SURVEY ON LOWER URINARY TRACT SYMPTOMS (LUTS) AMONG PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH) IN HOSPITAL UNIVERSITI SAINS MALAYSIA (HUSM)
Malaysian Journal of Medical Sciences, Vol. 14, No. 2, July 2007 (67-71) SHORT COMMUNICATION A SURVEY ON LOWER URINARY TRACT SYMPTOMS (LUTS) AMONG PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH) IN HOSPITAL
More informationUrinary Adverse Events after Radiation Therapy for Prostate Cancer
Urinary Adverse Events after Radiation Therapy for Prostate Cancer Sexual Medicine Society of North America Scottsdale, Arizona 2016 Jaspreet S. Sandhu, MD Department of Surgery/Urology Memorial Sloan
More informationClinical guideline Published: 23 May 2010 nice.org.uk/guidance/cg97
Lower urinary tract symptoms in men: management Clinical guideline Published: 23 May 2010 nice.org.uk/guidance/cg97 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationClinical Study Treatment Strategy According to Findings on Pressure-Flow Study for Women with Decreased Urinary Flow Rate
Advances in Urology Volume 2009, Article ID 782985, 5 pages doi:10.1155/2009/782985 Clinical Study Treatment Strategy According to Findings on Pressure-Flow Study for Women with Decreased Urinary Flow
More informationManaging urinary morbidity after brachytherapy. Kieran O Flynn Department of Urology, Salford Royal Foundation Trust, Manchester
Managing urinary morbidity after brachytherapy Kieran O Flynn Department of Urology, Salford Royal Foundation Trust, Manchester Themes Can we predict urinary morbidity? Prevention of urinary morbidity
More informationUrodynamic findings in women with insensible incontinence
bs_bs_banner International Journal of Urology (2013) 20, 429 433 doi: 10.1111/j.1442-2042.2012.03146.x Original Article: Clinical Investigation Urodynamic findings in women with insensible Benjamin M Brucker,
More informationNeuroanatomy, Neurophysiology and Clinical Presentation of Visceral Urological Pain
Neuroanatomy, Neurophysiology and Clinical Presentation of Visceral Urological Pain Prof Dr K. Everaert Functional urology Department of Urology Ghent University Hospital Gent, Belgium Chronic pelvic pain
More information5-8 July, 2008, Palais des Congrès, Paris, France
A review of the 4 th INTERNATIONAL CONSULTATION ON INCONTINENCE 5-8 July, 2008, Palais des Congrès, Paris, France The 4 th International Consultation on Incontinence was held 5-8 July 2008 in Paris and
More informationManagement of Female Stress Incontinence
Management of Female Stress Incontinence Dr. Arvind Goyal Associate Professor (Urology& Renal Transplant) Dayanand Medical College & Hospital, Ludhiana, Punjab, India Stress Incontinence Involuntary loss
More informationBladder dysfunction in ALD and AMN
Bladder dysfunction in ALD and AMN Sara Simeoni, MD Department of Uro-Neurology National Hospital for Neurology and Neurosurgery Queen Square, London 10:15 Dr Sara Simeoni- Bladder issues for AMN patients
More informationEAU GUIDELINES POCKET EDITION 3
EAU GUIDELINES POCKET EDITION 3 CONTENTS: BENIGN PROSTATIC HYPERPLASIA URINARY INCONTINENCE UROLITHIASIS 2 3 EAU POCKET GUIDELINES POCKET EDITION 3 This is one of a series of convenient pocket size books
More informationPROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment
PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA A Minimally Invasive Innovative Treatment What is the prostate? The prostate is an accessory organ of the male reproductive system.
More informationUrinary tract disorders
Urinary tract disorders Medicines Formulary Contents: 1. Urinary retention 1 2. Urinary incontinence 2 3. Urethral pain prevention during catheterisation 3 4. Indwelling catheters maintenance of patency
More informationDr. Aso Urinary Symptoms
Haematuria The presence of blood in the urine (haematuria) is always abnormal and may be the only indication of pathology in the urinary tract. False positive stick tests and the discolored urine caused
More informationManagement of Voiding Problems in Older Men. Dr. John Fenn Consultant, QEH 10 th October, 2005
Management of Voiding Problems in Older Men Dr. John Fenn Consultant, QEH 10 th October, 2005 Voiding Problems Poor stream Hesitancy Straining Incomplete emptying Intermittent micturition Terminal dribbling
More informationINTERSTITIAL CYSTITIS (IC) MANAGEMENT
INTERSTITIAL CYSTITIS (IC) MANAGEMENT About Interstitial Cystitis (IC) What is IC? IC is a chronic, yet manageable, bladder condition, characterized by bladder or pelvic pain, pain during or after sexual
More informationIndex. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablative therapies, transurethral needle ablation, Adverse events, sexual side effects of BPH Aging, and incidence of BPH associated with
More informationCase Report Transurethral Incision of the Bladder Neck in a Woman with Primary Bladder Neck Obstruction after Kidney Transplantation
Case Reports in Transplantation Volume 2015, Article ID 312084, 4 pages http://dx.doi.org/10.1155/2015/312084 Case Report Transurethral Incision of the Bladder Neck in a Woman with Primary Bladder Neck
More informationDOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI Page 1 Page 2 treatment of benign prostatic hyperplasia treatment of benign prostatic pdf treatment of benign prostatic
More informationBotulinum Toxin Injection for OAB: Indications & Technique
Classification of LUTS Botulinum Toxin Injection for OAB: Indications & Technique Sherif Mourad, MD Professor of Urology, Ain Shams University General Secretary of International Continence President of
More informationManagement of Voiding Dysfunction after Prostate Radiotherapy
Management of Voiding Dysfunction after Prostate Radiotherapy Up to Date Symposium on Uro-Oncology December 7, 2012 Belo Horizonte, Brazil Jaspreet S. Sandhu, MD Department of Surgery/Urology Memorial
More informationFlowmetry/ pelvic floor electromyographic findings in patients with detrusor overactivity
ORIGINAL ARTICLE Vol. 41 (3): 521-526, May - June, 2015 doi: 10.1590/S1677-5538.IBJU.2014.0204 Flowmetry/ pelvic floor electromyographic findings in patients with detrusor overactivity Farshid Alizadeh
More informationMODULE 3: BENIGN PROSTATIC HYPERTROPHY
MODULE 3: BENIGN PROSTATIC HYPERTROPHY KEYWORDS: Prostatic hypertrophy, prostatic hyperplasia, PSA, voiding dysfunction, lower urinary tract symptoms (LUTS) At the end of this clerkship, the medical student
More informationThe Neurogenic Bladder
The Neurogenic Bladder Outline Brandon Haynes, MD Resident Physician Department of Urology Jelena Svircev, MD Assistant Professor Department of Rehabilitation Medicine Anatomy and Bladder Physiology Bladder
More informationUrinary Incontinence. Vibhash Mishra Consultant Urological Surgeon Royal Free Hospital
Urinary Incontinence Vibhash Mishra Consultant Urological Surgeon Royal Free Hospital Affects women of all ages Impacts physical, psychological & social wellbeing Impact on families & carers Costs the
More information